EMAIL
info@prfbd.org
Call Now
+880 255 035 439
Home
About Us
Our Mission and Vision
Our Team
Our Partner
Our Donor
Our Work
Ongoing Projects
Completed Projects
Projahnmo AMNAHI Biobank
Our Reaserch Area
Demographic Surveillance
Hospital Surveillance
Study Laboratory
Data Management
Publications & News
Publications
News
Resources
Brochure
Manuals
Media Coverage
Gallery
Career with PRF
Donations
Career with PRF
Consultancy
Contact Us
Completed
PROJECTS
Home
/
Completed Projects
1. Community use of digital auscultation to improve diagnosis of childhood pneumonia in Sylhet, Bangladesh.
2. Digital Auscultation and Pulmonary Function Testing Among Rural Bangladeshi Infants.
3. Optimizing place of treatment and antibiotic regimens for young infants presenting with signs of possible serious bacterial infection.
4. Implementation research to support MOHFW to implement its national guidelines of management of infections in young infants in two rural districts of Bangladesh.
5. Enhanced community case management to increase access to pneumonia treatment.
6. A simple toolkit to aid community-based identification and management of premature and jaundiced newborns.
7. Prevalence of and risk factors for hypertension in a rural Bangladeshi adult population.
8. A Phase 3, Randomized, Observer-Blind, Placebo-Controlled, Group-Sequential Study to Determine the Immunogenicity and Safety of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine with Aluminum in Healthy Third-trimester Pregnant Women; and Safety and Efficacy of Maternally Transferred Antibodies in Preventing RSV Disease in their Infants.
9. The Consequence of Respiratory Syncytial Virus (RSV) Infection in Young Infants.
10. A multi-country, multicenter, two-arm, parallel, double-blind, placebo-controlled, randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low-resource countries to improve newborn outcomes (ACTION-I Trial).
11. Field-testing and validation of the Global Scale for Early Development (GSED) for 0- to 3-year-old children.
12. Cost-effectiveness of antenatal corticosteroids for women at risk of imminent preterm birth in the early preterm period in low resource countries.
13. COVID-19: Harnessing AMANHI Infrastructure to assess the direct impact on maternal, newborn and child health.